Interest of a Systematic One-year Monitoring by 18F-FDG PET-CT

Study of the Angiogenesis by PET/CT in Patients With Lymphoma

NCT02490891 ·Status: COMPLETED ·Phase: PHASE2

Dynamic F-DOPA PET for Differential Diagnosis Between Recurrence and Radionecrosis of Brain Metastasis

NCT05762172 ·Status: COMPLETED ·Phase: NA

Optimization of 18F-FDG PET/CT Response Assessment and Prognostic Evaluation Strategies for High-Metabolism Lymphoma

NCT06795113 ·Status: RECRUITING

Positron Emission Tomography(PET) in Lymphoma Assessment

NCT00887718 ·Status: COMPLETED ·Phase: NA

Contribution of the Imaging to the Expression of intégrines αvβ3 for the Characterization of Residual Masses of Non-seminoma Tumors at the End of Chemotherapy

NCT02317393 ·Status: COMPLETED ·Phase: PHASE2

The Prognostic Value of Interim PET/CT After 2 Cycles of Chemotherapy in Predicting Progression of Non Hodgkins Lymphoma

NCT00498667 ·Status: WITHDRAWN

Total-body PET / CT in the Evaluation of Treatment and Prognosis of Lymphoma

NCT04931875 ·Status: UNKNOWN

18F-FDG PET Scan and MRI Diffusion.Evaluation of the Early Therapeutic Response of Diffuse Large B-cell Lymphoma

NCT03121456 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA

Role of [18F]-FDG Brain PET in Newly Diagnosed Primary Cerebral Lymphoma, in Immunocompetent Patient Older Than 60 Years

NCT03582254 ·Status: UNKNOWN ·Phase: NA

Detection and Characterization of Residual Masses in Lymphomas

NCT02300402 ·Status: COMPLETED

Combining Intratumoral Metabolic Heterogeneity and Dissemination Feature (Dmax) on 18F-FDG PET/CT Improves Prognosis Prediction in DLBCL

NCT05113576 ·Status: COMPLETED

Comparison of 6-fluoro-[18F]-L-dihydroxyphenylalanine (18F-DOPA) Positron Emission Tomography (PET) and Multiparametric Resonance Magnetic Imagery (RMI) in Initial Exploration of Glial Tumors

NCT03525080 ·Status: COMPLETED ·Phase: NA

18FDG-PET in Patients With Melanoma or NSCLC Treated With Immunotherapy

NCT03741231 ·Status: COMPLETED

Assessment of Hematopoietic Recovery Following Chemotherapy for Non-Hodgkin's Lymphoma

NCT00775957 ·Status: TERMINATED

18F-FDG PET/CT-based Prognostic Model for Predicting Outcome in Patients With Diffuse Large B-cell Lymphoma

NCT02928861 ·Status: UNKNOWN ·Phase: NA

PET/CT Vs Bone Marrow Biopsy in Exclusion of Bone Marrow Infiltration for Initial Staging of Lymphoma

NCT05565898 ·Status: NOT_YET_RECRUITING

PET-based Evaluation of Chemotherapy-induced Brain Damage in Lymphoma

NCT02601547 ·Status: COMPLETED ·Phase: NA

Impact of [11C]-Methionine PET/MRI for Individual Tailoring Postoperative Radiochemotherapy for Glioblastoma Multiforme

NCT01873469 ·Status: COMPLETED

Creation of a Normal Database for FluoroDeoxyGlucose-Positron Emission Tomography (FDG-PET) Neurological Examinations

NCT02858167 ·Status: COMPLETED ·Phase: NA

Comparison of Diagnostic Performance of an Algorithm and a High Definition Classical Iterative Algorithm Positron Emission Tomography (PET) to 18Fluoro-deoxy-glucose (18FDG) in the Evaluation of Axillary Lymph Node Invasion of Breast Tumors

NCT01436591 ·Status: TERMINATED

18F-Fluoro-Ethyl-Tyrosine (FET) Positron Emission Tomography (PET) and Grading Glioma

NCT04001257 ·Status: COMPLETED

Positron Emission Tomography Using Fludeoxyglucose F 18 in Predicting Response to Treatment in Patients Who Are Receiving Rituximab and Combination Chemotherapy for Newly Diagnosed Non-Hodgkin's Lymphoma

NCT00110006 ·Status: WITHDRAWN ·Phase: NA

[18F]FPIA PET-CT in Glioblastoma Multiforme (GBM)

NCT05801159 ·Status: COMPLETED

Diagnostic Qualities of the Positron Emission Tomography Coupled to the Scanner (PET / CT) in the Assessment of Response to Non-Hodgkin's Lymphoma Therapy in Children and Adolescents

NCT02488369 ·Status: COMPLETED ·Phase: NA

PET/CT Whole-body Dynamic Acquisition at FDG to Metastatic Melanoma Under Immunotherapy

NCT04272658 ·Status: RECRUITING